Literature DB >> 25708032

Thromboelastography predictive of death in trauma patients.

Ian Kane1, Alvin Ong, Fabio R Orozco, Zachary D Post, Luke S Austin, Kris E Radcliff.   

Abstract

OBJECTIVES: To determine if thromboelastography (TEG) is predictive of patient outcomes following traumatic injury.
METHODS: A retrospective review of 131 patients with pelvic trauma admitted to a Level II trauma center was conducted over four years from 1 January 2009 to 31 December 2012. Patients were identified retrospectively from a prospectively collected database of acute pelvic trauma (n = 372). Eligible patients were identified from billing/coding data as having fractures of the acetabulum, iliac wing or sacral alae. Patients with incomplete TEG data were excluded (n = 241), as were patients with pathological fractures. TEG clotting variables and traditional clotting variables were recorded.
RESULTS: Evaluation of TEG data revealed 41 patients with abnormal clotting times (TEG R). TEG R > 6 was an independent risk factor for death (OR, 16; 95%CI 5.4-53; P = 0.0001). The death rate was 52% in patients with TEG R values ≥6 (n = 13/25). There was no significant association between traditional clotting markers and death rate.
CONCLUSIONS: TEG reaction time value, representing the time of initial clot formation, was the only hematologic marker predictive of mortality in patients with pelvic trauma. Delay in reaction time was associated with a significantly increased death rate, independent of injury severity. The death rate association was not observed with traditional markers of clotting. Future prospective studies may be warranted to determine the presentation and significance of TEG abnormalities when resuscitating patients with orthopaedic trauma.
© 2015 Chinese Orthopaedic Association and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Coagulopathy; Mortality; Thromboelastography

Mesh:

Year:  2015        PMID: 25708032      PMCID: PMC6583160          DOI: 10.1111/os.12158

Source DB:  PubMed          Journal:  Orthop Surg        ISSN: 1757-7853            Impact factor:   2.071


  6 in total

1.  F11 rs2289252T and rs2036914C Polymorphisms Increase the Activity of Factor XI in Post-trauma Patients with Fractures Despite Thromboprophylaxis.

Authors:  Nan Song; Ai-Xian Tian; Jian-Min Zhang; Hong-Qiang Jiang; Jia-Cheng Zang; Xin-Long Ma
Journal:  Orthop Surg       Date:  2016-08       Impact factor: 2.071

Review 2.  Targeted Thromboelastographic (TEG) Blood Component and Pharmacologic Hemostatic Therapy in Traumatic and Acquired Coagulopathy.

Authors:  Mark Walsh; Stephanie Fritz; Daniel Hake; Michael Son; Sarah Greve; Manar Jbara; Swetha Chitta; Braxton Fritz; Adam Miller; Mary K Bader; Jonathon McCollester; Sophia Binz; Alyson Liew-Spilger; Scott Thomas; Anton Crepinsek; Faisal Shariff; Victoria Ploplis; Francis J Castellino
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

3.  Traumatic Abdominal Solid Organ Injury Patients Might Benefit From Thromboelastography-Guided Blood Component Therapy.

Authors:  Hao Wang; Richard D Robinson; Jessica L Phillips; Andrew Ryon; Scott Simpson; Jonathan R Ford; Johnbosco Umejiego; Therese M Duane; Bradley Putty; Nestor R Zenarosa
Journal:  J Clin Med Res       Date:  2017-04-01

4.  Gender Differences do not Influence the Blood Coagulopathy in Patients Undergoing Total Knee Arthroplasty: A Retrospective Thromboelastography Analysis.

Authors:  Wang-Yi Jin; Yong Pang; Xing-Chen Zhang; Da-Lin Peng; Zi-Wen Yan; Sheng Pan; Chao-Ran Huang; Kai-Jin Guo; Xin Zheng
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

5.  Utility of viscoelastic hemostatic assay to guide hemostatic resuscitation in trauma patients: a systematic review.

Authors:  Zhe Zhu; Yong Yu; Kairui Hong; Mengqin Luo; Yefang Ke
Journal:  World J Emerg Surg       Date:  2022-09-13       Impact factor: 8.165

Review 6.  Viscoelastic Hemostatic Assays for Orthopedic Trauma and Elective Procedures.

Authors:  Christiaan N Mamczak; Jacob Speybroeck; John E Stillson; Joseph Dynako; Andres Piscoya; Ethan E Peck; Michael Aboukhaled; Emily Cancel; Michael McDonald; Diego Garcia; John Lovejoy; Stephanie Lubin; Robert Stanton; Matthew E Kutcher
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.